These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25951101)

  • 21. Landmark study shows chemotherapy improves survival in late-stage lung cancer patients.
    Oncology (Williston Park); 2000 Aug; 14(8):1154, 1176. PubMed ID: 10989826
    [No Abstract]   [Full Text] [Related]  

  • 22. Elderly patients with advanced non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2003 Sep; 5(2):76. PubMed ID: 14596687
    [No Abstract]   [Full Text] [Related]  

  • 23. [New trends in adjuvant chemotherapy for non-small-cell lung cancer].
    Dediu M; Alexandru A; Median D; Vremeş G
    Pneumologia; 2005; 54(2):89-93. PubMed ID: 16536008
    [No Abstract]   [Full Text] [Related]  

  • 24. [Role of chemotherapy in the treatment of advanced stage non-small-cell bronchial cancer].
    Sculier JP
    Rev Mal Respir; 1993; 10(4):287-9. PubMed ID: 8235020
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemotherapy for lung cancer].
    Kurata T; Fukuoka M
    Nihon Rinsho; 2002 May; 60 Suppl 5():309-16. PubMed ID: 12101679
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials referral resource. Clinical trials in non-small-cell lung cancer.
    Saxman SB; Blatner GL; Cheson BD
    Oncology (Williston Park); 1999 Oct; 13(10):1384, 1387-8. PubMed ID: 10549565
    [No Abstract]   [Full Text] [Related]  

  • 27. Missing patient-reported outcome data in an adjuvant lung cancer study.
    Land SR
    J Clin Oncol; 2008 Nov; 26(31):5018-9. PubMed ID: 18809601
    [No Abstract]   [Full Text] [Related]  

  • 28. The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer.
    Myerson JS; Faria A; Puglisi M; Starling N; Popat S; O'Brien ME
    Lung Cancer; 2010 Sep; 69(3):365-6. PubMed ID: 20655614
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic treatment of non-small-cell lung cancer.
    Lal R; Enting D; Kristeleit H
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S375-7. PubMed ID: 21944021
    [No Abstract]   [Full Text] [Related]  

  • 30. Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process.
    De Pas T; de Braud F; Veronesi G
    J Thorac Oncol; 2010 May; 5(5):754. PubMed ID: 20421773
    [No Abstract]   [Full Text] [Related]  

  • 31. [Taxol in bronchial carcinoma].
    Gatzemeier U
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
    [No Abstract]   [Full Text] [Related]  

  • 32. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P; Lagoudis M; Kostis E
    J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract]   [Full Text] [Related]  

  • 33. Can weight loss at presentation predict patient outcome in lung cancer?
    Temel J
    Nat Clin Pract Oncol; 2004 Dec; 1(2):68-9. PubMed ID: 16264819
    [No Abstract]   [Full Text] [Related]  

  • 34. Benefit of active treatment in non-small-cell lung cancer in elderly patients and patients with poor performance status.
    Lee D
    Clin Lung Cancer; 2003 Sep; 5(2):86-9. PubMed ID: 14596690
    [No Abstract]   [Full Text] [Related]  

  • 35. [Is it still allowable in 1994 to sanction therapeutic abstention for stage IIIB and IV non-small-cell bronchial cancer?].
    Souquet PJ; Lombard-Bohas CH; Bernard JP
    Rev Mal Respir; 1995; 12(1):71-2. PubMed ID: 7899675
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemotherapy and surgery in stage IIIa non-small cell lung cancer.
    Skarin AT
    J Thorac Oncol; 2007 Jun; 2(6):577-8. PubMed ID: 17545857
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of outcomes of Taxol + Cisplatin and Taxol + Nedaplatin chemotherapy regimens for advanced non-small cell lung cancer].
    Cai YP; Xu S; Lin SJ
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):74-5. PubMed ID: 20211076
    [No Abstract]   [Full Text] [Related]  

  • 38. PACIFIC: An Ocean of Hope in Patients With Stage III Unresectable Non-Small Cell Lung Cancer.
    Uprety D; Marinier DE
    J Natl Compr Canc Netw; 2018 May; 16(5):458-460. PubMed ID: 29752318
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment perspectives in advanced non-small cell lung cancer.
    Soto Parra H; Latteri F; Cavina R; Sala A; Dambrosio M; Alloisio M; Santoro A
    Tumori; 2000; 86(5 Suppl 1):S36-41. PubMed ID: 11195292
    [No Abstract]   [Full Text] [Related]  

  • 40. A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer.
    Chouaid C; Nathan F; Pemberton K; Morris T
    Cancer Chemother Pharmacol; 2011 May; 67(5):1203-8. PubMed ID: 21153822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.